small molecule

MEMANTINE HYDROCHLORIDE AND DONEPEZIL HYDROCHLORIDE

DONEPEZIL HYDROCHLORIDE; MEMANTINE HYDROCHLORIDE

Loss of exclusivity—loss of exclusivity
CompanyAmneal Pharmaceuticals →See this company's full patent-cliff portfolio

Drug detail

Brand nameMEMANTINE HYDROCHLORIDE AND DONEPEZIL HYDROCHLORIDE
Active ingredientDONEPEZIL HYDROCHLORIDE; MEMANTINE HYDROCHLORIDE
Strength10MG;7MG
Dosage formCAPSULE, EXTENDED RELEASE
RouteORAL
ModalitySmall molecule
FDA approvalFebruary 2025
Marketing statusRX

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.